Cargando…

ODP449 A Case of Malignant Struma Ovarii

A 45 year old female presented to the ER with pelvic pain. Ultrasound of the uterus revealed a left ovarian 8 cm dermoid cyst. She underwent a unilateral salpingo-hysterectomy. During the operation, no high risk features were seen including no ascites or adhesions. Final pathology revealed a 2.2 cm...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhusseini, Maha, Daher, Mona, Mehanna, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625605/
http://dx.doi.org/10.1210/jendso/bvac150.1552
_version_ 1784822541010862080
author Alhusseini, Maha
Daher, Mona
Mehanna, Reem
author_facet Alhusseini, Maha
Daher, Mona
Mehanna, Reem
author_sort Alhusseini, Maha
collection PubMed
description A 45 year old female presented to the ER with pelvic pain. Ultrasound of the uterus revealed a left ovarian 8 cm dermoid cyst. She underwent a unilateral salpingo-hysterectomy. During the operation, no high risk features were seen including no ascites or adhesions. Final pathology revealed a 2.2 cm papillary thyroid cancer with no other worrisome features (no angio-invasion or lymphatic invasion). A diagnosis of malignant struma ovarii was made, and the patient was referred to endocrinology for further work up. A neck US was performed revealed a benign looking, partially cystic, 0.8 cm right thyroid nodule. An FNA attempted came back non-diagnostic. Thyroid functions and baseline thyroglobulin were normal. The clinical dilemna that came up was how to approach the thyroid gland status since in the majority of thyroid cancer cases, the thyroid gland is removed. On review of over 200 cases reported in the literature of localized malignant struma ovarii, the majority of the cases were treated with pelvic surgery alone, and the thyroid gland was left in place. There is no available data that removing the thyroid gland in these patients decreases the risk of recurrence of thyroid cancer. Given the lack of any high risk features in our patient, it was decided not to pursue further adjuvant treatment and to continue surveillance with a repeat of thyroglobulin level in 6 months. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9625605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96256052022-11-14 ODP449 A Case of Malignant Struma Ovarii Alhusseini, Maha Daher, Mona Mehanna, Reem J Endocr Soc Thyroid A 45 year old female presented to the ER with pelvic pain. Ultrasound of the uterus revealed a left ovarian 8 cm dermoid cyst. She underwent a unilateral salpingo-hysterectomy. During the operation, no high risk features were seen including no ascites or adhesions. Final pathology revealed a 2.2 cm papillary thyroid cancer with no other worrisome features (no angio-invasion or lymphatic invasion). A diagnosis of malignant struma ovarii was made, and the patient was referred to endocrinology for further work up. A neck US was performed revealed a benign looking, partially cystic, 0.8 cm right thyroid nodule. An FNA attempted came back non-diagnostic. Thyroid functions and baseline thyroglobulin were normal. The clinical dilemna that came up was how to approach the thyroid gland status since in the majority of thyroid cancer cases, the thyroid gland is removed. On review of over 200 cases reported in the literature of localized malignant struma ovarii, the majority of the cases were treated with pelvic surgery alone, and the thyroid gland was left in place. There is no available data that removing the thyroid gland in these patients decreases the risk of recurrence of thyroid cancer. Given the lack of any high risk features in our patient, it was decided not to pursue further adjuvant treatment and to continue surveillance with a repeat of thyroglobulin level in 6 months. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625605/ http://dx.doi.org/10.1210/jendso/bvac150.1552 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thyroid
Alhusseini, Maha
Daher, Mona
Mehanna, Reem
ODP449 A Case of Malignant Struma Ovarii
title ODP449 A Case of Malignant Struma Ovarii
title_full ODP449 A Case of Malignant Struma Ovarii
title_fullStr ODP449 A Case of Malignant Struma Ovarii
title_full_unstemmed ODP449 A Case of Malignant Struma Ovarii
title_short ODP449 A Case of Malignant Struma Ovarii
title_sort odp449 a case of malignant struma ovarii
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625605/
http://dx.doi.org/10.1210/jendso/bvac150.1552
work_keys_str_mv AT alhusseinimaha odp449acaseofmalignantstrumaovarii
AT dahermona odp449acaseofmalignantstrumaovarii
AT mehannareem odp449acaseofmalignantstrumaovarii